Literature DB >> 14556775

Congenital neutropenia.

Philip James Ancliff1.   

Abstract

Congenital neutropenia is strictly defined as neutropenia present at birth. However, it is more generally used to describe neutropenia secondary to inherited genetic mutations. This review will discuss the presentation of such children and the various causes of congenital neutropenia. In particular, it will focus on severe congenital neutropenia (SCN) and the recent discovery of mutations in the gene encoding neutrophil elastase in the majority of cases of SCN. The potential mechanisms of pathogenesis and of transformation to leukaemia will be discussed. Shwachman-Diamond Syndrome and other less common causes of congenital neutropenia will also be reviewed. Finally, an approach to the child with potential congenital neutropenia will be presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556775     DOI: 10.1016/s0268-960x(03)00019-5

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  11 in total

1.  Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.

Authors:  Philip S Rosenberg; Cornelia Zeidler; Audrey A Bolyard; Blanche P Alter; Mary A Bonilla; Laurence A Boxer; Yigal Dror; Sally Kinsey; Daniel C Link; Peter E Newburger; Akiko Shimamura; Karl Welte; David C Dale
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Novel ELANE Gene Mutation in a Newborn with Severe Congenital Neutropenia: Case Report and Literature Review.

Authors:  Yue Jia; Changjun Yue; Kathryn Bradford; Xin Qing; Eduard H Panosyan; Moran Gotesman
Journal:  J Pediatr Genet       Date:  2019-11-18

Review 4.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

5.  Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes.

Authors:  Lisa S Westerberg; Parool Meelu; Marisa Baptista; Michelle A Eston; David A Adamovich; Vinicius Cotta-de-Almeida; Brian Seed; Michael K Rosen; Peter Vandenberghe; Adrian J Thrasher; Christoph Klein; Frederick W Alt; Scott B Snapper
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

6.  Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.

Authors:  Philip S Rosenberg; Blanche P Alter; Daniel C Link; Steven Stein; Elin Rodger; Audrey A Bolyard; Andrew A Aprikyan; Mary A Bonilla; Yigal Dror; George Kannourakis; Peter E Newburger; Laurence A Boxer; David C Dale
Journal:  Br J Haematol       Date:  2007-11-20       Impact factor: 6.998

7.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

8.  Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase.

Authors:  Stephen J Salipante; Meghan E B Rojas; Brice Korkmaz; Zhijun Duan; Jeremy Wechsler; Kathleen F Benson; Richard E Person; H Leighton Grimes; Marshall S Horwitz
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

9.  Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS.

Authors:  Peter Vandenberghe; Karolien Beel
Journal:  Pediatr Rep       Date:  2011-06-22

10.  Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia.

Authors:  Dale A Moulding; Michael P Blundell; David G Spiller; Michael R H White; Giles O Cory; Yolanda Calle; Helena Kempski; Jo Sinclair; Phil J Ancliff; Christine Kinnon; Gareth E Jones; Adrian J Thrasher
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.